INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

26,743 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$167K
3,258 sh
Feb 19, 2026
Page 503 of 669
← PrevNext →
Feb 23, 2026
traded Feb 19, 2026
+4d
SEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
1,492 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

16
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$61K
1,217 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

4
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$135K
1,730 sh
Feb 20, 2026Feb 23, 2026
traded Feb 20, 2026
+3dSEC Form 4

Evidence

4
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$162K
2,084 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

34
Robert P. Bresnahan, Jr.RSelf
PBPhiladelphia, PA Municipal Bond
Purchase
BUY$50K – $100KFeb 3, 2026Feb 22, 2026
traded Feb 3, 2026
+19dHouse PTR

Evidence

24
Robert P. Bresnahan, Jr.RSelf
ANadvisors. I have no role in, nor am informed of, specific investment decisions prior to their execution. Accordingly, this transaction was planned and executed by a financial advisor. US Treasury Note 01/31/27
Purchase
BUY$1,001 – $15KFeb 3, 2026Feb 22, 2026
traded Feb 3, 2026
+19dHouse PTR

Evidence

51
AS
Aslam ShakilChief Medical Officer
TLPHTALPHERA, INC.
Open-market purchase
BUY$28K
35.0K sh
Feb 12, 2026Feb 20, 2026
traded Feb 12, 2026
+8dSEC Form 4

Evidence

47
MA
Mattson Michelle AnnSecretary
NANAKeystone Private Income Fund
Open-market purchase
BUY$20K
203 sh
Feb 1, 2026Feb 20, 2026
traded Feb 1, 2026
+19dSEC Form 4

Evidence

44
David J. TaylorRSelf
AMZNAMAZON COM INC
Purchase
BUY$1,001 – $15KFeb 9, 2026Feb 20, 2026
traded Feb 9, 2026
+11dHouse PTR

Evidence

42
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale
SELL$595K
10.1K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

35
FR
Fukushima RyanChief Executive Officer, Data
TEMTempus AI, Inc.
Open-market sale
SELL$566K
9,592 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

34
David J. TaylorRSelf
VVISA INC.
Purchase
BUY$1,001 – $15KFeb 9, 2026Feb 20, 2026
traded Feb 9, 2026
+11dHouse PTR

Evidence

34
David J. TaylorRSelf
CRMSalesforce, Inc.
Purchase
BUY$1,001 – $15KFeb 9, 2026Feb 20, 2026
traded Feb 9, 2026
+11dHouse PTR

Evidence

34
David J. TaylorRSelf
PGPROCTER & GAMBLE Co
Purchase
BUY$1,001 – $15KFeb 9, 2026Feb 20, 2026
traded Feb 9, 2026
+11dHouse PTR

Evidence

33
LR
Lerner Lorena RaquelChief Science Officer
KROSKeros Therapeutics, Inc.
Open-market sale
SELL$63K
3,873 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

33
CE
Cho EstherSVP, General Counsel
KROSKeros Therapeutics, Inc.
Open-market sale
SELL$78K
4,745 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

31
TJ
Tasker Anthony JamesSVP & COO
FUNCFIRST UNITED CORP/MD/
Open-market sale
SELL$33.11
1 sh
Feb 4, 2026Feb 20, 2026
traded Feb 4, 2026
+16dSEC Form 4

Evidence

30
David J. TaylorRSelf
LLYELI LILLY & Co
Sale
SELL$1,001 – $15KFeb 9, 2026Feb 20, 2026
traded Feb 9, 2026
+11dHouse PTR

Evidence

29
CG
Casella Matthew G.Former officer
RRRICHTECH ROBOTICS INC.
Open-market sale
SELL$34K
12.5K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

29
David J. TaylorRSelf
MSFTMICROSOFT CORP
Purchase
BUY$1,001 – $15KFeb 9, 2026Feb 20, 2026
traded Feb 9, 2026
+11dHouse PTR

Evidence

29
Tim MooreRSelf
TAT&T INC.
Sale
SELL$15K – $50KJan 30, 2026Feb 20, 2026
traded Jan 30, 2026
+21dHouse PTR

Evidence

28
Tim MooreRSelf
SMPLSimply Good Foods Co
Purchase
BUY$15K – $50KFeb 3, 2026Feb 20, 2026
traded Feb 3, 2026
+17dHouse PTR

Evidence

28
Tim MooreRSelf
HOGHARLEY-DAVIDSON, INC.
Purchase
BUY$15K – $50KJan 23, 2026Feb 20, 2026
traded Jan 23, 2026
+28dHouse PTR

Evidence

28
CG
Campbell Darrell GeorgeEVP - CFO
SNDRSchneider National, Inc.
Open-market sale
SELL$173K
6,000 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
WR
Webb Michael ReedSVP & Chief Admin Officer
ROGROGERS CORP
Open-market sale
SELL$127K
1,197 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
GS
Griffis SarahChief Technology Officer
MAPSWM TECHNOLOGY, INC.
Open-market sale
SELL$183K
271.0K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

26
PE
Phelps ErikEVP, Chief Admin. Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$334K
5,650 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

25
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$65K
10.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

25
Tim MooreRSelf
COINCoinbase Global, Inc.
Sale
SELL$1,001 – $15KFeb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dHouse PTR

Evidence

24
Tim MooreRSelf
DNUTKrispy Kreme, Inc.
Purchase
BUY$1,001 – $15KFeb 12, 2026Feb 20, 2026
traded Feb 12, 2026
+8dHouse PTR

Evidence

24
Tim MooreRSelf
SMPLSimply Good Foods Co
Purchase
BUY$15K – $50KFeb 11, 2026Feb 20, 2026
traded Feb 11, 2026
+9dHouse PTR

Evidence

24
Tim MooreRSelf
VZVERIZON COMMUNICATIONS INC
Sale
SELL$15K – $50KJan 30, 2026Feb 20, 2026
traded Jan 30, 2026
+21dHouse PTR

Evidence

24
Tim MooreRSelf
GNPXGenprex, Inc.
Purchase
BUY$1,001 – $15KFeb 5, 2026Feb 20, 2026
traded Feb 5, 2026
+15dHouse PTR

Evidence

24
David J. TaylorRSelf
PGRPROGRESSIVE CORP/OH/
Purchase
BUY$1,001 – $15KFeb 10, 2026Feb 20, 2026
traded Feb 10, 2026
+10dHouse PTR

Evidence

23
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$654K
10.8K sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

23
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$481K
8,143 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

22
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$58K
711 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

22
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$19K
3,016 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

22
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$56K
698 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence